SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome.

Nademanee, K; Veerakul, G; Nogami, A; Lou, Q; Hocini, M; Coronel, R; Behr, ER; Wilde, A; Boukens, BJ; Haissaguerre, M (2022) Mechanism of the effects of sodium channel blockade on the arrhythmogenic substrate of Brugada syndrome. Heart Rhythm, 19 (3). pp. 407-416. ISSN 1556-3871 https://doi.org/10.1016/j.hrthm.2021.10.031
SGUL Authors: Behr, Elijah Raphael

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (2MB) | Preview
[img]
Preview
PDF Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives.

Download (18MB) | Preview

Abstract

BACKGROUND: The mechanisms by which sodium channel blockade and high-rate pacing modify electrogram (EGM) substrates of Brugada syndrome (BrS) have not been elucidated. OBJECTIVE: The purpose of this study was to determine the effect of ajmaline and high pacing rate on the BrS substrates. METHODS: Thirty-two patients with BrS (mean age 40 ± 12 years) and frequent ventricular fibrillation episodes underwent right ventricular outflow tract substrate electroanatomical and electrocardiographic imaging (ECGI) mapping before and after ajmaline administration and during high-rate atrial pacing. In 4 patients, epicardial mapping was performed using open thoracotomy with targeted biopsies. RESULTS: Ajmaline increased the activation time delay in the substrate (33%; P = .002), ST-segment elevation in the right precordial leads (74%; P < .0001), and the area of delayed activation (170%; P < .0001), coinciding with the increased substrate size (75%; P < .0001). High atrial pacing rate increased the abnormal EGM duration at the right ventricular outflow tract areas from 112 ± 48 to 143 ± 66 ms (P = .003) and produced intermittent conduction block and/or excitation failure at the substrate sites, especially after ajmaline administration. Biopsies from the 4 patients with thoracotomy showed epicardial fibrosis where EGMs were normal at baseline but became fractionated after ajmaline administration. In some areas, local activation was absent and unipolar EGMs had a monophasic morphology resembling the shape of the action potential. CONCLUSION: Sodium current reduction with ajmaline severely compromises impulse conduction at the BrS fibrotic substrates by producing fractionated EGMs, conduction block, or excitation failure, leading to the Brugada ECG pattern and favoring ventricular fibrillation genesis.

Item Type: Article
Additional Information: © 2021 Heart Rhythm Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Keywords: Brugada syndrome, Catheter ablation, Fibrosis, Sodium channel blocker, Ventricular fibrillation, Brugada Syndrome, catheter ablation, ion channelopathy, sodium channel blocker, sudden death, Cardiovascular System & Hematology, 1102 Cardiorespiratory Medicine and Haematology, 0903 Biomedical Engineering
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: Heart Rhythm
ISSN: 1556-3871
Language: eng
Dates:
DateEvent
25 February 2022Published
4 November 2021Published Online
26 October 2021Accepted
Publisher License: Creative Commons: Attribution-Noncommercial-No Derivative Works 4.0
Projects:
Project IDFunderFunder ID
RHYTHMLeducq FoundationUNSPECIFIED
16CVD02Leducq FoundationUNSPECIFIED
2016T047Dutch Heart FoundationUNSPECIFIED
PubMed ID: 34742919
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/113865
Publisher's version: https://doi.org/10.1016/j.hrthm.2021.10.031

Actions (login required)

Edit Item Edit Item